Advertisement
Research Article

A Role of SCN9A in Human Epilepsies, As a Cause of Febrile Seizures and As a Potential Modifier of Dravet Syndrome

  • Nanda A. Singh mail,

    nsingh@genetics.utah.edu

    Affiliation: Department of Human Genetics, University of Utah, Salt Lake City, Utah, United States of America

    X
  • Chris Pappas,

    Affiliation: Department of Human Genetics, University of Utah, Salt Lake City, Utah, United States of America

    X
  • E. Jill Dahle,

    Affiliation: Department of Human Genetics, University of Utah, Salt Lake City, Utah, United States of America

    X
  • Lieve R. F. Claes,

    Affiliation: VIB Department of Molecular Genetics, University of Antwerp, Antwerp, Belgium

    X
  • Timothy H. Pruess,

    Affiliation: Department of Pharmacology and Toxicology, Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, Utah, United States of America

    X
  • Peter De Jonghe,

    Affiliation: VIB Department of Molecular Genetics, University of Antwerp, Antwerp, Belgium

    X
  • Joel Thompson,

    Affiliation: Division of Pediatric Neurology, University of Utah, Salt Lake City, Utah, United States of America

    X
  • Missy Dixon,

    Affiliation: Department of Human Genetics, University of Utah, Salt Lake City, Utah, United States of America

    X
  • Christina Gurnett,

    Affiliation: Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Andy Peiffer,

    Affiliation: Division of Medical Genetics, University of Utah, Salt Lake City, Utah, United States of America

    X
  • H. Steve White,

    Affiliation: Department of Pharmacology and Toxicology, Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, Utah, United States of America

    X
  • Francis Filloux,

    Affiliation: Division of Pediatric Neurology, University of Utah, Salt Lake City, Utah, United States of America

    X
  • Mark F. Leppert

    Affiliation: Department of Human Genetics, University of Utah, Salt Lake City, Utah, United States of America

    X
  • Published: September 18, 2009
  • DOI: 10.1371/journal.pgen.1000649

About the Authors

Nanda A. Singh, Chris Pappas, E. Jill Dahle, Missy Dixon, Mark F. Leppert
Department of Human Genetics, University of Utah, Salt Lake City, Utah, United States of America
Lieve R. F. Claes, Peter De Jonghe
VIB Department of Molecular Genetics, University of Antwerp, Antwerp, Belgium
Timothy H. Pruess, H. Steve White
Department of Pharmacology and Toxicology, Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, Utah, United States of America
Joel Thompson, Francis Filloux
Division of Pediatric Neurology, University of Utah, Salt Lake City, Utah, United States of America
Christina Gurnett
Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America
Andy Peiffer
Division of Medical Genetics, University of Utah, Salt Lake City, Utah, United States of America

Corresponding Author

Email: nsingh@genetics.utah.edu

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: NAS CP EJD MFL. Performed the experiments: NAS CP EJD THP. Analyzed the data: NAS CP EJD HSW FF MFL. Contributed reagents/materials/analysis tools: LRFC PDJ JT MD CG AP HSW FF. Wrote the paper: NAS HSW FF MFL.